Gilead to Buy Maker of Cancer Treatments for $11.9 Billion

The deal to acquire Kite, whose drugs use the body’s immune system as a weapon, is Gilead’s biggest effort to date to find a new blockbuster product.

from NYT > Health http://ift.tt/2wbNogL
via health&fitness